Edgar Filing: CorMedix Inc.

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

TELLEZ CORA M

2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [CRMD]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O CORMEDIX INC., 1430 HIGHWAY 206, SUITE 200

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2017

(Street)

BEDMINSTER, NJ 07921

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2017		P		4,800 ⁽¹⁾	A	$ 0.6575	124,821	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option (Right to Buy Common Stock)

$ 2.24

⁽²⁾

02/21/2027

Common Stock

40,000

Restricted Stock Units

⁽³⁾

Common Stock

20,714

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

3,472

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

4,143

Stock Option (Right to Buy Common Stock)

$ 2.05

⁽⁵⁾

04/03/2024

Common Stock

30,000

Stock Option (Right to Buy Common Stock)

$ 5.62

⁽²⁾

03/01/2025

Common Stock

50,000

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

4,205

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

2,873

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

1,371

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

2,868

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

3,645

Stock Option (Right to Buy Common Stock)

$ 1.91

⁽²⁾

02/21/2026

Common Stock

100,000

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

4,104

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

2,767

Phantom Stock

$ 0 ⁽⁴⁾

⁽⁴⁾

Common Stock

4,335

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
TELLEZ CORA M C/O CORMEDIX INC. 1430 HIGHWAY 206, SUITE 200 BEDMINSTER, NJ 07921	X

Signatures

/s/ Alexander M. Donaldson, by Power of Attorney		05/03/2017
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016.
(2)	These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(3)	Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(4)	Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
(5)	The options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant, and 1/3 on the second anniversary of the date of grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.